Meat Glue | Market Size, Share & Growth Report 2025-2033

    The Meat Glue Market Report is Segmented by Product Type (Transglutaminase Enzyme Powder, Liquid Enzyme, and Microbial Enzymes), Application (Meat Products, Seafood Products, Dairy Products, Convenience Foods, and Others), Distribution Channel (Online Stores, Supermarkets/Hypermarkets, Specialty Stores, and Others), Ingredient Type (TGase, Casein, Gelatin, Albumen, and Others).

    Base Year: 20255 RegionsForecast 2025–2033255 Pages
    Market Size (2025)
    USD 607.5 million
    CAGR
    6.60%
    Forecast Value (2033)
    USD 1.01 billion

    Meat Glue Market

    6.60% CAGR

    Market Size & Share

    2025 to 2033 forecast analysis

    Market Size (2025)
    USD 607.5 million
    CAGR
    6.60%
    (2025–2033)
    Forecast (2033)
    USD 1.01 billion

    Key Findings

    Market reaches USD 1.01 billion by 2033

    The global meat glue market was estimated at approximately USD 607.5 million in 2025 and is projected to reach around USD 1.01 billion by 2033, a CAGR of approximately 6.60%. The magnitude follows the broader enzyme measurement of USD 593.8 million for 2024 rather than the USD 136.51 million recorded for microbial transglutaminase alone, because this report covers formulated binder systems including casein, gelatin and albumen.

    One originator against regional challengers

    Ajinomoto Co., Inc. developed and commercialised the category from Japan and remains the reference supplier. BDF Natural Ingredients, S.L. competes from Spain on formulation, Shanghai Kinry Food Ingredients Co., Ltd. and Yiming Biological Products Co., Ltd. supply enzyme from China at lower cost, and Micro-Tech Foods Ingredients, Inc. manufactures by fermentation in the United States.

    Binding uses the meat's own protein

    The strongest verified reason for growth is that the enzyme forms covalent bonds between glutamine and lysine residues already present in the product, so trimmings and small cuts bind into a piece that survives slicing and cooking. That turns low-value material into portion-controlled product without adding bulk, and the enzyme is inactivated by cooking.

    European authorisation unresolved since 2009

    The principal constraint is regulatory. Regulation (EC) 1332/2008 has required a European Union positive list of permitted food enzymes since January 2009, and Ajinomoto's dossier for transglutaminase from Streptoverticillium mobaraense strain S-8112 remains under assessment alongside two further strains, so the enzyme is used under differing national rules.

    Microbial production defines the product type

    Within product type, essentially all food-grade transglutaminase is produced by fermentation rather than extracted from animal tissue, so the microbial category overlaps the others almost completely instead of dividing the market. Powder dominates because the enzyme is blended with a carrier for dosing, which is the difference between the USD 136.51 million and USD 593.8 million measurements.

    Asia Pacific holds production and demand

    Asia Pacific is the largest regional market, with Ajinomoto producing in Japan and Shanghai Kinry Food Ingredients and Yiming Biological Products in China, alongside long-established surimi manufacturing that depends on protein gelation. No published regional market size or growth figure for transglutaminase was identified for any region, so the ranking rests on documented commercial concentration rather than measured revenue.

    Market Analysis

    How the market stands today, and what is shaping it

    The global meat glue market was estimated at approximately USD 607.5 million in 2025 and is projected to reach around USD 1.01 billion by 2033, representing a CAGR of approximately 6.60% during 2025-2033, based on Core Market Research estimates. The market covers binding systems for restructured meat, seafood, dairy and convenience foods, led by microbial transglutaminase supplied as a powder blended with a carrier, and including the casein, gelatin and albumen binders used alongside or instead of it. Growth rests on the enzyme forming covalent bonds between glutamine and lysine residues already present, so trimmings bind into a piece that survives slicing and cooking without added bulk, and on suppliers selling formulated systems that address firmness, elasticity and liquid retention together. The constraint is regulatory: Regulation (EC) 1332/2008 has required a European positive list since January 2009 and the assessment remains incomplete, so the enzyme is used under differing national rules. Ajinomoto Co., Inc. is the originator and reference supplier, ahead of BDF Natural Ingredients, S.L., Shanghai Kinry Food Ingredients Co., Ltd., Yiming Biological Products Co., Ltd. and Micro-Tech Foods Ingredients, Inc. Asia Pacific holds both production and demand.

    Market Dynamics

    Key market dynamics and their impact on the industry landscape

    Market Drivers

    • Transglutaminase binds meat using the proteins already present, forming covalent bonds between glutamine and lysine residues. That lets processors turn trimmings and small cuts into a piece holding together through slicing and cooking, which turns low-value material into portion-controlled product without adding bulk or extenders.
    • Suppliers sell formulated systems rather than raw enzyme, which widens what the product delivers. BDF Natural Ingredients specifies its PROBIND series for meat and fish to improve firmness, elasticity, viscosity, thermo-stability and liquid retention, so a single addition addresses several processing problems that would otherwise need separate ingredients.
    • United States regulatory treatment through the Generally Recognized As Safe pathway has given transglutaminase a settled status without prior authorisation. That contrasts with the European Union, where Regulation (EC) 1332/2008 has required a positive list since January 2009 and the assessment of Ajinomoto's strain remains incomplete.
    • The enzyme is catalytic and is inactivated by cooking, so it performs its function and then ceases to act. That behaviour is what allows binding without the added bulk or texture penalty that gelatin and albumen carry, and it underpins dairy use where firmness rises without added stabilisers.
    • Production capacity has broadened beyond the originating supplier. Shanghai Kinry Food Ingredients has manufactured the enzyme under its Biobond brand since its founding in 2002, Yiming Biological Products supplies TG-A and TG-B grades from Jiangsu, and Micro-Tech Foods Ingredients manufactures by fermentation in the United States.

    Market Challenges

    • The European regulatory position has been unresolved for more than fifteen years. Regulation (EC) 1332/2008 required a positive list of permitted food enzymes from January 2009, and Ajinomoto's dossier for the Streptoverticillium mobaraense strain remains under evaluation, so the enzyme is used under differing national rules rather than a single authorisation.
    • The common name works against the product. Describing a food enzyme as meat glue frames a catalytic protein cross-linker as an adhesive, and that framing shaped public expectations about declaration in restructured products even in jurisdictions where the technical rules did not change.
    • Published measurements disagree by more than fourfold. Microbial transglutaminase alone was valued at USD 136.51 million in 2024 while the broader enzyme market was placed at USD 593.8 million and a third series at USD 246 million, and the difference is carrier and formulation rather than different products.
    • Formed meat carries declaration obligations that whole cuts do not. Products bound from pieces have to be identified as formed or restructured in several jurisdictions, which constrains where the technique can be used commercially and means an export processor satisfies the destination market's rules rather than its own.
    • Dosing is unforgiving. Setting depends on dose, holding temperature and time matched to a specific product and line, and an incorrectly dosed binder either fails to hold or produces a rubbery texture, which is why suppliers sell with technical support rather than from a catalogue.

    Opportunities

    • Completion of the European positive list could settle a market that has operated on interim national rules since 2009. If the European Food Safety Authority assessment concludes favourably for the submitted strains, suppliers would gain a single authorisation across the European Union in place of differing Member State treatments.
    • Dairy texture is an application where the enzyme competes against declared additives rather than against other binders. Cross-linking raises firmness and reduces syneresis in yoghurt and cheese without a stabiliser appearing on the label, which may suit manufacturers reformulating toward shorter declarations.
    • Plant protein structuring could extend the enzyme beyond animal products. Transglutaminase acts on glutamine and lysine residues wherever they occur, so legume and other plant proteins are potential substrates, and texture is the principal unsolved problem in that category.
    • Formulated systems may capture value that raw enzyme supply does not. BDF Natural Ingredients competes from Europe on PROBIND formulations rather than on enzyme production, which suggests specialists can hold margin against lower-cost Asian enzyme manufacturing by selling the application rather than the molecule.
    • Certified supply chains could become a commercial position in halal markets. Because certification extends to the fermentation substrate, a producer documenting its growth medium end to end may gain preferred status with Gulf and other certified processors over suppliers unable to evidence it.

    Segment Analysis

    Market segmentation by product type, application, distribution channel, ingredient type

    The three supplied categories are not parallel alternatives, and the relationship between them is worth stating directly. Microbial enzymes describe the source: commercial transglutaminase is produced by fermentation rather than extracted from animal tissue, and Micro-Tech Foods Ingredients manufactures it by that route. Essentially all food-grade transglutaminase sold today is microbial, so this category and the others overlap almost completely rather than dividing the market. Powder is the dominant physical form because the enzyme is blended with a carrier for dosing: Ajinomoto's Activa TG-TI, sold as Activa WM in Europe, combines microbial transglutaminase with maltodextrin. Liquid enzyme preparations serve applications where a slurry or brine is injected rather than a dry blend applied to a surface. The published measurements reflect this overlap: microbial transglutaminase alone was valued at USD 136.51 million in 2024 while the broader enzyme market was placed at USD 593.8 million, and the difference is carrier and formulation rather than different enzymes.

    Geography Analysis

    Regional market analysis

    Largest Market
    Asia Pacific
    Fastest Growing
    Asia Pacific

    Asia Pacific

    Asia Pacific is the largest regional market for this category and also its manufacturing base, which is the clearest structural fact about the market's geography. Ajinomoto developed and commercialised the Activa range from Japan, and Shanghai Kinry Food Ingredients produces the enzyme in China under its Biobond brand, describing itself as the country's sole professional manufacturer of transglutaminase. Yiming Biological Products supplies from Jiangsu with its TG-A and TG-B grades. Demand matches supply here because surimi and other protein-gelation products are a long-established part of regional food manufacturing rather than a recent introduction. The evidentiary limit should be recorded plainly: no published regional market size, revenue or growth figure for transglutaminase was identified for any region. The ranking therefore rests on documented commercial concentration, specifically that four of the enzyme's named producers operate here, rather than on measured regional revenue.

    North America

    North America is a substantial consuming market served largely by imported enzyme and by domestic formulators. Micro-Tech Foods Ingredients manufactures transglutaminase by fermentation and supplies a range of grades for cross-linking meat proteins. United States regulatory treatment differs from the European approach: transglutaminase is handled through the Generally Recognized As Safe pathway rather than through a positive list requiring prior authorisation, which has given the enzyme a settled status here for longer. Restructured and formed meat products are well established in foodservice and institutional supply, where portion consistency and yield matter more than the appearance of a whole muscle cut. The region is also where the enzyme attracted the most public attention under the meat glue name, which shaped labelling expectations even where it did not change the rules. No published figure reports North American transglutaminase revenue separately.

    Latin America

    Latin America is a mid-sized consuming region with a large processed meat sector and no significant enzyme production of its own. Brazil is one of the world's largest beef and poultry processors and exporters, which creates substantial demand for binding systems in restructured and formed products supplied to both domestic and export markets. Argentina and Mexico add further processed meat volume. Because export products have to satisfy the labelling rules of the destination market rather than only local ones, Brazilian processors supplying Europe face the formed-meat declaration requirements that apply there regardless of where the product was made. Supply reaches the region through distributors and through the regional operations of the European and Asian producers. No published figure isolates Latin American transglutaminase revenue, so the regional position is inferred from processed meat output rather than measured directly.

    Europe

    Europe is the region where the enzyme's regulatory position remains least settled, and that uncertainty shapes the market more than demand does. Regulation (EC) 1332/2008 was enacted in January 2009 to establish a positive list of permitted food enzymes following assessment by the European Food Safety Authority, and Ajinomoto's dossier for transglutaminase from Streptoverticillium mobaraense strain S-8112 remains under evaluation alongside submissions covering two further strains. Until the list is complete, the enzyme is used under existing national rules, which differ between Member States. BDF Natural Ingredients supplies from Spain with its PROBIND formulations, and European suppliers compete on formulation rather than on enzyme production. Ajinomoto markets its range here under separate codes, with Activa TG-TI sold as Activa WM and Activa TG-RM as Activa EB. No published European revenue figure for this market was identified.

    Middle East & Africa

    The Middle East and Africa is the smallest region for this category and the one where religious certification interacts most directly with the product. Halal certification requires the processing aid and its fermentation substrate to satisfy the same requirements as the food itself, so a microbial enzyme produced by fermentation needs documentation of its growth medium rather than only of its own composition. That requirement favours suppliers able to provide certified production chains and adds an approval step that does not exist elsewhere. Processed and restructured meat demand is concentrated in Gulf foodservice and in institutional catering, both largely supplied by import. South African processed meat manufacturing is the principal sub-Saharan outlet. Supply reaches the region through distributors rather than through local production. No published figure reports regional transglutaminase revenue separately.

    Competitive Landscape

    Key players and market positioning analysis

    This market has one originator and a group of later entrants competing on different bases, and the split runs along regional lines. Ajinomoto is the reference supplier, having developed and commercialised the Activa range from Japan, and its product structure shows how the category is actually sold. Activa TG-TI, marketed as Activa WM in Europe, combines microbial transglutaminase with maltodextrin, and the range extends through Activa TG-FP, TG-GS, TG-RM, sold as Activa EB in Europe, and Activa MP. Different codes for different applications and regions reflect a business built on matching dose and carrier to a process rather than on selling one enzyme. Shanghai Kinry Food Ingredients produces the enzyme in China under the Biobond brand and describes itself as the only professional manufacturer of transglutaminase in the country, having been founded in 2002 with roughly two decades of food enzyme research behind it. Yiming Biological Products supplies TG-A and TG-B grades from Jiangsu. Those two put cost pressure on enzyme supply, which is why European and American participants position differently. BDF Natural Ingredients competes from Spain on its PROBIND series of functional formulations specified for meat and fish to improve firmness, elasticity, viscosity, thermo-stability and liquid retention, selling the application rather than the molecule. Micro-Tech Foods Ingredients manufactures by fermentation in the United States, where the Generally Recognized As Safe pathway gives the enzyme a settled status that European suppliers still lack. Competition turns on carrier formulation, technical support for dosing and regulatory documentation.

    5 companies profiled in this report

    Major Players

    Leading companies in the market

    A
    Ajinomoto Co., Inc.
    Japan
    B
    BDF Natural Ingredients, S.L.
    Spain
    S
    Shanghai Kinry Food Ingredients Co., Ltd.
    China
    Y
    Yiming Biological Products Co., Ltd.
    China
    M
    Micro-Tech Foods Ingredients, Inc.
    United States

    Industry Developments

    6 recorded developments

    2025

    Shanghai Kinry Food Ingredients continued producing transglutaminase under its Biobond brand, describing itself in 2025 as China's sole professional manufacturer of the enzyme. The company was founded in 2002 and positions on roughly two decades of research experience in food enzymes rather than on scale alone.

    2024

    Ajinomoto's dossier for transglutaminase derived from Streptoverticillium mobaraense strain S-8112 remained under evaluation by the European Food Safety Authority, with two further strains submitted by other companies. More than fifteen years after the regulation took effect, the enzyme's European status still rests on national rules rather than a completed list.

    2024

    Published measurements of the transglutaminase market for 2024 ranged from USD 136.51 million for microbial transglutaminase alone to USD 593.8 million for the broader enzyme market and USD 246 million on a third definition. The spread reflects whether formulated binder systems are counted alongside the enzyme itself.

    2024

    A forecast published in December 2024 placed the transglutaminase market on a path to USD 1.21 billion by 2034 from USD 593.8 million in 2024, identifying meat processing as the principal application driver. That trajectory implies the enzyme growing faster than the processed meat output it serves.

    2024

    BDF Natural Ingredients continued marketing its PROBIND series of European functional formulations built on transglutaminase, specified for meat and fish preparations to improve firmness, elasticity, viscosity, thermo-stability and liquid retention. Selling a formulation rather than the raw enzyme is how European suppliers compete against Asian enzyme producers.

    2009

    Regulation (EC) 1332/2008 on food enzymes was enacted in January 2009, requiring a European Union positive list of permitted enzymes established after assessment by the European Food Safety Authority. Until that list is complete, food enzymes may be placed on the market under existing national rules in each Member State.

    Table of Contents

    13 comprehensive chapters

    1. Introduction

    1.1 Market Definition

    1.2 Scope of the Study

    1.3 Research Objectives

    2. Research Methodology

    2.1 Research Approach

    2.2 Data Sources

    2.3 Market Estimation Approach

    2.4 Forecast Assumptions

    2.5 Research Limitations

    3. Executive Summary and Market Overview

    3.1 Market Overview

    3.2 Market Size and Forecast

    3.3 Key Findings

    3.4 Market Structure

    4. Market Dynamics

    4.1 Market Drivers

    4.2 Market Challenges

    4.3 Market Opportunities

    4.4 Market Trends and Insights

    5. Market Segmentation Analysis

    5.1 Market Segmentation Overview

    5.2 By Product Type

    5.3 By Application

    5.4 By Distribution Channel

    5.5 By Ingredient Type

    6. Geographic Analysis

    6.1 Asia Pacific

    6.2 North America

    6.3 Latin America

    6.4 Europe

    6.5 Middle East & Africa

    6.6 Regional Market Comparison

    7. Industry Analysis and Developments

    7.1 Industry Developments

    7.2 Industry Timeline

    8. Competitive Landscape

    8.1 Market Structure and Competitive Positioning

    8.2 Major Players

    8.3 Strategic Developments

    8.4 Key Competitive Factors

    9. Key Player Profiles

    9.1 Ajinomoto Co., Inc.

    9.2 BDF Natural Ingredients, S.L.

    9.3 Shanghai Kinry Food Ingredients Co., Ltd.

    9.4 Yiming Biological Products Co., Ltd.

    9.5 Micro-Tech Foods Ingredients, Inc.

    10. Market Outlook and Forecast

    10.1 Market Size and Growth Outlook

    10.2 Regional Market Outlook

    10.3 Future Market Trends

    10.4 Key Risks to the Forecast

    11. Strategic Insights and Market Opportunities

    11.1 Growth Opportunities

    11.2 Key Risks and Constraints

    11.3 Strategic Considerations

    12. Frequently Asked Questions
    13. Appendix and Research References

    13.1 Glossary of Terms

    13.2 Abbreviations

    13.3 Research References

    Scope of the Report

    Report coverage and methodology

    Study Period

    Base Year: 2025
    Forecast Period: 2025 - 2033

    Geographic Scope

    Asia Pacific, North America, Latin America, Europe, Middle East & Africa

    Companies Covered

    Ajinomoto Co., Inc., BDF Natural Ingredients, S.L., Shanghai Kinry Food Ingredients Co., Ltd., Yiming Biological Products Co., Ltd. + more

    Data Sources

    Primary research, industry interviews, regulatory filings, company reports

    Frequently Asked Questions

    Common questions about this report

    The global meat glue market was estimated at approximately USD 607.5 million in 2025, based on Core Market Research estimates.

    Ready to Get the Full Report?

    Access comprehensive market insights, detailed analysis, and strategic recommendations to make informed business decisions.

    Single User
    $3,600
    Multi User
    $5,760
    Enterprise
    $7,920